Article
Increased GPC4 and clusterin associated with insulin resistance in patients with PCOS
22 Jan 2024
Abstract excerpt
The aim of the study was to investigate the changes in serum glypican 4 (GPC4) and clusterin (CLU) levels in patients with polycystic ovary syndrome (PCOS) as well as their correlation with sex hormones and metabolic parameters. A total of 40 PCOS patients and 40 age-matched healthy women were selected. Serum GPC4 and CLU levels were compared between the PCOS and control groups, and binary logistic regression was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
